Settling the Score: Which Fibrosis Screening Tool Is the Most Reliable for Nonalcoholic Fatty Liver Disease?
Dig Dis Sci
.
2023 Jun;68(6):2217-2220.
doi: 10.1007/s10620-023-07899-0.
Epub 2023 Mar 22.
Authors
Halim Bou Daher
1
,
Paul Manka
2
,
Wing-Kin Syn
3
4
Affiliations
1
Department of Internal Medicine, Saint Louis University, St Louis, MO, USA. halim.boudaher@health.slu.edu.
2
Department of Internal Medicine, University Hospital Knappschaftskrankenhaus Bochum, Ruhr University Bochum, Bochum, Germany.
3
Department of Internal Medicine, Saint Louis University, St Louis, MO, USA.
4
Division of Gastroenterology and Hepatology, Saint Louis University, St Louis, MO, USA.
PMID:
36947290
DOI:
10.1007/s10620-023-07899-0
No abstract available
Publication types
Editorial
Comment
MeSH terms
Biopsy
Fibrosis
Humans
Liver / pathology
Liver Cirrhosis / diagnosis
Liver Cirrhosis / pathology
Non-alcoholic Fatty Liver Disease* / diagnosis
Non-alcoholic Fatty Liver Disease* / pathology